Andrea L Ciaranello

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. pmc Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe
    Andrea L Ciaranello
    Medical Practice Evaluation Center, Divisions of Infectious Disease, Massachusetts General Hospital, Boston, MA 02114, USA
    Clin Infect Dis 56:430-46. 2013
  2. pmc What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis
    Andrea L Ciaranello
    Division of Infectious Disease, Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA
    PLoS Med 9:e1001156. 2012
  3. pmc Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009
    Sophie Desmonde
    INSERM, U897 and Institut de Santé Publique, Epidémiologie et Développement ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    BMC Infect Dis 11:182. 2011
  4. ncbi request reprint Providing health care services to the formerly homeless: a quasi-experimental evaluation
    Andrea L Ciaranello
    Massachusetts General Hospital, USA
    J Health Care Poor Underserved 17:441-61. 2006
  5. pmc WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers
    Andrea L Ciaranello
    Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America
    PLoS ONE 6:e20224. 2011
  6. pmc Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions
    Andrea L Ciaranello
    Division of Infectious Disease, Massachusetts General Hospital, and Center for AIDS Research, Harvard Medical School, Boston, MA, USA
    BMC Med 9:59. 2011
  7. pmc First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial
    Andrea L Ciaranello
    Division of Infectious Disease, Massachusetts General Hospital, Boston, 02114, USA
    AIDS 25:479-92. 2011
  8. pmc Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity
    Andrea L Ciaranello
    Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    AIDS 22:2359-69. 2008
  9. ncbi request reprint Vesiculopapular rash
    Andrea L Ciaranello
    Division of Infectious Disease, Massachusetts General Hospital, Boston, MA 02114, USA
    Clin Infect Dis 43:1308, 1368-9. 2006
  10. pmc Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis
    Andrea L Ciaranello
    The Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Clin Infect Dis 49:1915-27. 2009

Detail Information

Publications17

  1. pmc Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe
    Andrea L Ciaranello
    Medical Practice Evaluation Center, Divisions of Infectious Disease, Massachusetts General Hospital, Boston, MA 02114, USA
    Clin Infect Dis 56:430-46. 2013
    ..We projected clinical impacts, costs, and cost-effectiveness of WHO-recommended PMTCT strategies in Zimbabwe...
  2. pmc What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysis
    Andrea L Ciaranello
    Division of Infectious Disease, Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA
    PLoS Med 9:e1001156. 2012
    ..We investigated uptake of prevention of MTCT (PMTCT) services, infant feeding recommendations, and specific drug regimens necessary to achieve this goal in Zimbabwe...
  3. pmc Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009
    Sophie Desmonde
    INSERM, U897 and Institut de Santé Publique, Epidémiologie et Développement ISPED, Universite Victor Segalen Bordeaux 2, Bordeaux, France
    BMC Infect Dis 11:182. 2011
    ..Clinical evolution of HIV-infected children who have not yet initiated antiretroviral treatment (ART) is poorly understood in Africa. We describe severe morbidity and mortality of untreated HIV-infected children...
  4. ncbi request reprint Providing health care services to the formerly homeless: a quasi-experimental evaluation
    Andrea L Ciaranello
    Massachusetts General Hospital, USA
    J Health Care Poor Underserved 17:441-61. 2006
    ..At 6 months, residents at the intervention sites also experienced improved blood pressure control. There was no intervention effect on residents' access to specialists or on physical functioning, mental health, or dental health...
  5. pmc WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers
    Andrea L Ciaranello
    Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America
    PLoS ONE 6:e20224. 2011
    ..The Zimbabwean national prevention of mother-to-child HIV transmission (PMTCT) program provided primarily single-dose nevirapine (sdNVP) from 2002-2009 and is currently replacing sdNVP with more effective antiretroviral (ARV) regimens...
  6. pmc Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions
    Andrea L Ciaranello
    Division of Infectious Disease, Massachusetts General Hospital, and Center for AIDS Research, Harvard Medical School, Boston, MA, USA
    BMC Med 9:59. 2011
    ....
  7. pmc First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial
    Andrea L Ciaranello
    Division of Infectious Disease, Massachusetts General Hospital, Boston, 02114, USA
    AIDS 25:479-92. 2011
    ..nevirapine-based antiretroviral therapy (ART) among women previously exposed to single-dose nevirapine to prevent mother-to-child HIV transmission. However, lopinavir/ritonavir is 12 times costlier than nevirapine...
  8. pmc Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity
    Andrea L Ciaranello
    Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    AIDS 22:2359-69. 2008
    ..We sought to identify the currently recommended regimen to prevent mother-to-child transmission that optimally balances risks of pediatric HIV infection and neurologic mitochondrial toxicity...
  9. ncbi request reprint Vesiculopapular rash
    Andrea L Ciaranello
    Division of Infectious Disease, Massachusetts General Hospital, Boston, MA 02114, USA
    Clin Infect Dis 43:1308, 1368-9. 2006
  10. pmc Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis
    Andrea L Ciaranello
    The Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Clin Infect Dis 49:1915-27. 2009
    ..We sought to derive pooled estimates of the 12-month rate of virologic suppression (HIV RNA, <400 copies/mL) and gain in CD4 cell percentage (DeltaCD4%) for children initiating ART in resource-limited settings...
  11. pmc Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents
    Andrea L Ciaranello
    Division of Infectious Disease, Massachusetts General Hospital, Boston, MA 02114, USA
    HIV Clin Trials 10:13-24. 2009
    ..We describe the frequency with which these posttrial services are described in the protocols and informed consent forms (ICFs) of antiretroviral drug (ARV) trials...
  12. pmc The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa
    Julie H Levison
    Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA 02114, USA
    Clin Infect Dis 56:587-97. 2013
    ..After adherence counseling, these patients may safely and effectively continue first-line ART, thereby delaying more expensive second-line ART...
  13. ncbi request reprint Individualizing the WHO HIV and infant feeding guidelines: optimal breastfeeding duration to maximize infant HIV-free survival
    Andrea L Ciaranello
    aMedical Practice Evaluation Center, Division of Infectious Disease, Massachusetts General Hospital, Boston, Massachusetts, USA bUniversité Bordeaux, Institut de Santé Publique, d Epidémiologie et de Développement ISPED, and Centre INSERM U897 Epidemiologie Biostatistique, Bordeaux, France cDivision of General Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA dHarvard Center for AIDS Research, Boston, Massachusetts, USA eDivision of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA fDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, USA gThe Botswana Harvard School of Public Health, AIDS Institute Partnership for HIV Research and Education, Gaborone, Botswana hOrganization for Public Health Interventions and Development, Harare, Zimbabwe iDivision of Infectious Disease, Brigham and Women s Hospital, Boston, Massachusetts, USA
    AIDS 28:S287-99. 2014
    ....
  14. pmc Cost-effectiveness of laboratory monitoring in sub-Saharan Africa: a review of the current literature
    Rochelle P Walensky
    Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
    Clin Infect Dis 51:85-92. 2010
    ....
  15. pmc Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis
    Rochelle P Walensky
    Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
    PLoS Med 7:e1000382. 2010
    ..This paper considers what to do first in resource-limited settings where immediate implementation of all of the WHO recommendations is not feasible...
  16. pmc Validation and Calibration of a Computer Simulation Model of Pediatric HIV Infection
    Andrea L Ciaranello
    Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, United States of America Division of Infectious Diseases, Brigham and Women s Hospital, Boston, Massachusetts, United States of America
    PLoS ONE 8:e83389. 2013
    ..We internally validated and then calibrated a model of HIV disease in children before initiation of antiretroviral therapy to provide a framework against which to compare the impact of pediatric HIV treatment strategies...
  17. pmc Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA
    H E Hsu
    Harvard Medical School, Boston, MA, USA
    HIV Med 12:97-108. 2011
    ..The aim of the study was to quantify the benefits (life expectancy gains) and risks (efavirenz-related teratogenicity) associated with using efavirenz in HIV-infected women of childbearing age in the USA...